Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The CDKN2A tumour suppressor gene: no mutations detected in patients with melanoma and additional unrelated cancers.

Melanoma research - 1 Dec 2002

Alao J P, Mohammed M Q, Retsas S

Abstract excerpt

Germ-line mutations of the CDKN2A tumour suppressor gene have been reported in association with familial melanoma, sporadic melanoma with multiple primary lesions and also pancreatic cancer. We studied the hypothesis that patients with melanoma and additional unrelated cancers may harbour mutations in the CDKN2A gene. Twenty seven patients with histologically confirmed melanoma who also had additional cancers...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromosomes, Human, Pair 9
Share to DNA Mutational Analysis
Share to DNA, Neoplasm

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genes, p16

Share to Genes, Tumor Suppressor

Share to Melanoma

Share to Neoplasms, Multiple Primary

Share to Skin Neoplasms

Source

Identifiers

PMID: 12459645
DOI: 10.1097/00008390-200212000-00005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The CDKN2A tumour suppressor gene: no mutations detected in patients with melanoma and additional unrelated cancers.PMID 12459645Read ↗

CDKN2A mutations in multiple primary melanomas.Semantic proximity Read ↗

Prospective risk of cancer in CDKN2A germline mutation carriersSemantic proximity Read ↗

Sporadic multiple primary melanoma cases: CDKN2A germline mutations with a founder effect.Semantic proximity Read ↗

Increased prevalence of lung, breast, and pancreatic cancers in addition to melanoma risk in families bearing the cyclin-dependent kinase inhibitor 2A mutation: implications for genetic counseling.Semantic proximity Read ↗

Role of the <i>CDKN2A</i> Locus in Patients With Multiple Primary MelanomasSemantic proximity Read ↗

Risk of non-melanoma cancers in first-degree relatives of CDKN2A mutation carriers.Semantic proximity Read ↗

Genetic and environmental influences in the development of multiple primary melanoma.Semantic proximity Read ↗

Cancer risks and survival in patients with multiple primary melanomas: Association with family history of melanoma and germline CDKN2A mutation status.Semantic proximity Read ↗

CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas.Semantic proximity Read ↗

Increased risk of cancer other than melanoma in CDKN2A founder mutation (p16-Leiden)-positive melanoma families.Semantic proximity Read ↗

Germline mutations in CDKN2A are infrequent in female patients with melanoma and breast cancer.Semantic proximity Read ↗

Brief report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.